Back
Dermata Therapeutics, Inc. Stock Price Chart
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
12
DRMA
Dermata Therapeutics, Inc.
Last Price:
$2.14
Seasonality Move:
-34.61%
7 Day Trial
ALL ACCESS PASS
$
7
Valuation Up 5,000%. Shares Now $0.85 - Still Early?
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRMA is experiencing slight selling pressure.
Dermata Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.63 | Sell |
| 20-day SMA: | 2.75 | Sell |
| 50-day SMA: | 3.3 | Sell |
| 200-day SMA: | 6.44 | Sell |
| 8-day EMA: | 2.56 | Sell |
| 20-day EMA: | 2.77 | Sell |
| 50-day EMA: | 3.36 | Sell |
| 200-day EMA: | 9.57 | Sell |
Dermata Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.24 | Sell |
| Relative Strength Index (14 RSI): | 32.66 | Sell |
| Chaikin Money Flow: | -27259 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.54 - 3.04) | Sell |
| Bollinger Bands (100): | (3.15 - 5.81) | Sell |
Dermata Therapeutics, Inc. Technical Analysis
| Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Dermata Therapeutics, Inc. Stock
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 2.30 while DRMA 8-day simple moving average is 2.63, which is a Sell signal.
-
The stock price of DRMA is 2.30 while Dermata Therapeutics, Inc. 20-day SMA is 2.75, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day simple moving average is 3.30 while DRMA share price is 2.30, making it a Sell technically.
-
DRMA stock price is 2.30 and Dermata Therapeutics, Inc. 200-day simple moving average is 6.44, creating a Sell signal.
DRMA Technical Analysis vs Fundamental Analysis
Sell
12
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Is Dermata Therapeutics, Inc. a Buy or a Sell?
-
Dermata Therapeutics, Inc. stock is rated a SellThe current Dermata Therapeutics, Inc. [DRMA] share price is $2.30. The Score for DRMA is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
Dermata Therapeutics, Inc. Stock Info
Market Cap:
2.4M
Price in USD:
2.30
Share Volume:
66.3K
Dermata Therapeutics, Inc. 52-Week Range
52-Week High:
23.70
52-Week Low:
2.21
Sell
12
Dermata Therapeutics, Inc. (DRMA)
is a Sell
Dermata Therapeutics, Inc. Share Price Forecast
-
What is the Dermata Therapeutics, Inc. stock price today?The Dermata Therapeutics, Inc. stock price is 2.30 USD today.
-
Will DRMA stock go up or go down?Dermata Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Dermata Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Dermata Therapeutics, Inc. is overvalued.
Is Dermata Therapeutics, Inc. Stock a Buy?
-
Dermata Therapeutics, Inc. share price is 2.30 while DRMA 8-day exponential moving average is 2.56, which is a Sell signal.
-
The stock price of DRMA is 2.30 while Dermata Therapeutics, Inc. 20-day EMA is 2.77, which makes it a Sell.
-
Dermata Therapeutics, Inc. 50-day exponential moving average is 3.36 while DRMA share price is 2.30, making it a Sell technically.
-
DRMA stock price is 2.30 and Dermata Therapeutics, Inc. 200-day simple moving average is 9.57, creating a Sell signal.
Technical Analysis of Dermata Therapeutics, Inc.
Should I short Dermata Therapeutics, Inc. stock?
-
DRMA Moving Average Covergence Divergence (MACD) indicator is -0.24, suggesting Dermata Therapeutics, Inc. is a Sell
-
Dermata Therapeutics, Inc. Relative Strength Index (RSI) is 32.66, which suggest Dermata Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Dermata Therapeutics, Inc. is (2.54 - 3.04), which suggest Dermata Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Dermata Therapeutics, Inc. is (3.15 - 5.81), which suggest Dermata Therapeutics, Inc. is a Sell
* Dermata Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.